1. Cancer and aging: symposium of the 27th annual meeting of the Japanese society for biomedical gerontology, Tokyo

   • Masanobu Kitagawa
   • Masanori Utsuyama
   • Katsuiku Hirokawa

   Review 01 December 2004 Pages: 623 - 634

   

2. A phase I/II trial of oxidized autologous tumor vaccines during the “watch and wait” phase of chronic lymphocytic leukemia

   • David E. Spaner
   • Caitlin Hammond
   • Andrea Deabreu

   Original Article 17 December 2004 Pages: 635 - 646

   

3. Local interleukin 2 therapy is most effective against cancer when injected intratumourally

   • John J. L. Jacobs
   • Derek Sparendam
   • Willem Den Otter

   Original Article 01 February 2005 Pages: 647 - 654

   

4. CD95/Apo-1/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes

   • Irmela Jeremias
   • Karsten Stahnke
   • Klaus -Michael Debatin

   Original Article 10 February 2005 Pages: 655 - 662

   

5. Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide

   • Lorenz Höltl
   • Reinhold Ramoner
   • Martin Thurnher

   Original Article 17 December 2004 Pages: 663 - 670

   

6. Apoptosis and production of TNF-α by tumor-associated inflammatory cells in histological grade III breast cancer

   • Farias Rogério Estevam
   • Soares Fernando Augusto
   • Aarestrup Fernando Monteiro

   Original Article 30 December 2004 Pages: 671 - 676

   

7. High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells

   • Angelika B. Riemer
   • Brigitte Hantusch
   • Erika Jensen-Jarolim

   Original Article 24 November 2004 Pages: 677 - 684

   

8. Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens

   • Li Li
   • Peter Reinhardt
   • Michael Schmitt

   Original Article 31 December 2004 Pages: 685 - 693

   

9. Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer

   • Susan F. Slovin
   • Govind Ragupathi
   • Howard I. Scher

   Original Article 22 February 2005 Pages: 694 - 702

   

10. Identification of a potential human telomerase reverse transcriptase–derived, HLA-A1–restricted cytotoxic T-lymphocyte epitope

    • Marco W. J. Schreurs
    • Esther W. M. Kueter
    • Erik Hooijberg

    Original Article 22 February 2005 Pages: 703 - 712

    

11. A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor

    • Axel Bex
    • Henk Mallo
    • Gijsbert C. de Gast

    Original Article 31 December 2004 Pages: 713 - 719